VRC-CHKVLP059-00-VP vaccine: Phase I data

Researchers at NIH's National Institute of Allergy and Infectious Diseases (NIAID) reported data from an open-label, dose-escalation, U.S. Phase I trial in 25 healthy volunteers aged 18-50 years showi...